Randomised controlled trial of Withania somnifera root powder in Parkinson’s Disease

ISRCTN ISRCTN31871098
DOI https://doi.org/10.1186/ISRCTN31871098
Secondary identifying numbers N/A
Submission date
16/02/2010
Registration date
07/06/2010
Last edited
07/06/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Muhammad Fahad Saleem
Scientific

A-1 Pakarab Fertilizer Housing Colony
Multan
75600
Pakistan

Phone +92 (0)32 18203914
Email fahad.saleem@aku.edu

Study information

Study designRandomised double blind placebo controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Participant information sheet Not available in web format, please email fahad.saleem@aku.edu to request a patient information sheet.
Scientific titleRandomised placebo-controlled trial of adjuvant therapy with Withania somnifera in Parkinson’s Disease
Study acronymWiS-PD
Study objectives3 grams per day of Withania somnifera root powder, as an adjuvant therapy to standard care, would improve Unified Parkinson's Disease Rating System (UPDRS) score by more than 10 points in patients with Parkinson’s disease compared to placebo.
Ethics approval(s)Ethical Review Committee of Aga Khan University Hospital, Karachi approved on the 28th of August 2009 (ref: 1266/CHS/ERC-09)
Health condition(s) or problem(s) studiedParkinson's disease
InterventionWithania Somnifera root powder and placebo
Intervention typeOther
Primary outcome measureEfficacy, assessed by Modified Unified Parkinson's Disease Rating System (UPDRS) scale at baseline and 4 weeks.
Secondary outcome measuresSafety, assessed by Modified UPDRS scale at baseline and 4 weeks.
Overall study start date01/04/2010
Completion date30/06/2010

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants30
Key inclusion criteria1. Patients, of either sex, aged 30-65, with mild to moderate Parkinson's Disease
2. Levodopa-responsive and participants demonstrate some identifiable 'on response' as observed by investigator
3. Participants demonstrate severe motor fluctuations in spite of individually optimized levodopa treatment investigator.
Key exclusion criteria1. Diagnosis is unclear or a suspicion of other Parkinsonian syndromes. A group of diseases characterised by symptoms (e.g. tremour, rigidity or stiffness, slow movements and difficulty maintaining balance) common in Parkinson's disease like:-
1.1. Patients with Parkinson’s Plus syndromes
1.2. Essential tremors
1.3. Dementia with Lewy bodies
1.4. Progressive supranuclear palsy
1.5. The syndromes of olivopontocerebellar atrophy
1.6. Striatonigral degeneration
1.7. Shy-Drager
2. Undergone surgery for the treatment of PD
3. Contraindications to levodopa, or a condition which makes the treatment inadvisable
4. People with any neurological deficit that may interfere with the study assessments
5. Any sign of infection any where in the body at the time of assessment
6. Pregnant or lactating
Date of first enrolment01/04/2010
Date of final enrolment30/06/2010

Locations

Countries of recruitment

  • Pakistan

Study participating centre

A-1 Pakarab Fertilizer Housing Colony
Multan
75600
Pakistan

Sponsor information

Higher Education Commission of Pakistan (HEC) (Pakistan)
Government

c/o Mr. Abid Ali Gohar (Director Research and Development)
Islamabad
75600
Pakistan

Phone +92 (0)51 90401910
Email aagohar@hec.gov.pk
Website http://www.hec.gov.pk
ROR logo "ROR" https://ror.org/038y3sz68

Funders

Funder type

Government

Higher Education Commission of Pakistan (HEC) (Pakistan)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan